| Financial Year |
March 31 2023 |
| Monetary Funds |
276,618,690.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
41,527,899.34 |
| Accounts Receivable |
735,005,419.55 |
| Advances to Suppliers |
30,713,461.49 |
| Other Receivables |
27,427,744.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
60,935,232.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,174,962.76 |
| Total Current Assets |
1,439,391,039.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
152,080,610.20 |
| Under-construction Projects |
143,014,063.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
82,695,763.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
451,070.28 |
| Deferred Income Tax Assets |
12,564,824.59 |
| Other Non-Current Assets |
68,094,367.80 |
| Sub-Total of Non-Current Assets |
489,112,929.91 |
| Total Assets |
1,928,503,969.53 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
176,466,841.74 |
| Accounts Payable |
33,082,365.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,978,894.65 |
| Taxes Payable |
8,916,042.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,189,561.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,445,226.44 |
| Other Current Liabilities |
3,956,709.26 |
| Sub-Total of Current Liabilities |
274,548,789.56 |
| Long-term Loans |
97,979,622.02 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,446,204.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
105,321,981.47 |
| Total Liabilities |
379,870,771.03 |
| Paid-In Capital(Or Share Stock) |
210,104,233.00 |
| Capital Surplus |
436,278,210.68 |
| Surplus Reserve |
74,900,817.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
827,542,047.65 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,548,633,198.50 |
| Owner's Equity（Stockholder's Equity） |
1,548,633,198.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,928,503,969.53 |
